THE SCIENTIFIC AND MEDICAL
NETWORK
(Company limited by Guarantee No. 04544694
Registered Charity no. 01101171)
REPORT AND FINANCIAL STATEMENTS
YEAR ENDED: 315tDECEMBER, 2023
'AD8V0vDL•
0510812024
COMPANIES HOUSE
A16
#276
DAWE, HAWKEN & DODD
Chartered Certified Accountants
Callington, Comwall.

THE SCIENTIFIC AND MEDICAL NETWORK
(Company limited by Guarantee No. 0454494, Registered Charity No. 1101171)
REPORT & FINANCIAL STATEMENTS
YEAR ENDED 31" DECEMBER, 2023
CONTENTS
Page
Legal and Administrative Inforniation
Board of Trustees, Report
Independent Examiner's Report
Statement of Financial Activities
Balance Sh¢¢t
Cash Flow Stalem¢nt
Notes lo the Financial Ststements
9-15

THE SCIENTIFIC AND MEDICAL IYETWORK
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY,
ITS TRUSTEES AND ADVISERS
FOR THE YEAR ENDED 31"DECEMBER 2023
President
Professor Bernard Carr
MA, PhD
Vice Presidents
Professor John Clarke
Diana Clift
Professor Marilyn Monk
BA, MA
MA, MPhil
Emeritus Professor of Molecular
Embryology, PhD, Msc
Claudia Nielsen
Martin Redfern
BA
Board of Trnstees
Dr. Paul Filmor¢ (resigned S Dec 2023)
PhD, MBA, MlnstPhys, CPhys,
FHEA, FRSA
BSC, MA Astronomy, Msc
G¢ophysics
BA, BL
Bst, MBA
Pl￿, MSo¢Sci, Dipsw, CQSW,
BA(Hons)
Bsc, Msc, PhD
Paul Kieniewi¢z
Jaqueline Nielsen
Tuvi Orbach
Dr. Joan Walton
Dr. Vasileios Basios
Company Se¢retiry
Nicholas Pilbrow (resigned 20 De¢ 2023)
Chiara Reghellin {appointed 20 Dec 2023
resigned 5 July 2024)
Nicholas Pilbrow (appointed 5 July 2024)
FCA
PhD
Tre*$ur¢r
Paul Filmore (￿signed 8 D¢¢ 2023)
PhD, MBA, MlnslPhys, CPhys,
FHEA, FRSA
BS¢, FCA
Graham Wilkins (Appointed 8 Dec 2023)
Programme Director & Editor
of "N¢twork R¢vi¢w"
David Lorimer
MA, PGCE, FRSA
Consultant to
The Board
Dr. Oliver Robinson
MA, MSC, PhD
Network Manager
Andrew Polson
MA
Accounts
Chiara R¢ghellin
PhD
Company Reg. No.
04544694
Charity No.
1101171
Registered Office
52 Fore Street
Callington
Cornwall, PL17 7AJ
Independent Examiner
A. M. Fa￿. FCCA
Dawe, Hawken & Dodd
Chartered Certified A¢￿untsnts
52 Fore Street
Callington
Cornwall, PL17 7AJ
Bankers
Barclays Bank PIC
CAF Bank

THE SCIENTIFIC AND MEDICAL NETWORK
BOARD OF TRUSTEES, REPORT
FOR THE YEAR ENDED 31$¢ DECEMBEIL 2023
The Board of Truslees. who are also Directors of the Company for the purposes of the Companies Act. and Trustees for
charity law purposes, submit their annual r¢port and the financial statements of The Scientific and Medical Network for the
year ended 31 1¢ December, 2023. The Board of Trustees confirnis that the annual report and financial statements of the
Company comply with current statutory requirements, the requirements of ihe Company's governing document and the
provisions of the Statement of Recommended Practice (FRS 102).
STRUCTURE, GOVERNANCE AND MANAGEMENT
irfal Status
The Scientific and Medical Network is a company limited by 8uarantee and governed by its Memorandum dnd Articles of
Association. The Directors of ihe Company are Trusiees in a¢¢ordance with the Charities Act 2011.
Rlsk Assessment
The Directors review financial and oiher risks when appropriate and have established pro¢edures lo ensure that all
transactions and projects are properly auihorised,
Directorat¢ and M¢mbers' Int¢rests
The Directors of the Company on I st January 2023 were Dr. Paul Filmore (Chairnian), Ms. Jaqueline Nielsen, Mr. Paul
Kieniewicz, Mr. Tuvi Orbach, Dr. Joan Walion & Dr. Vasileios Basios. At the Annual General Meeting of the Company
held on 9 July 2023, Mrs Jacqueline Neilson and Dr. Va5ileios Basios retired by rotstion and were re-elected. DT. Paul
Filmore resigned on 8 December, 2023.
Ea¢h year on¢ third of the memb¢r appointed Dire¢lors, who have served the longest, retire by rotstion. They are, if they
wish, eligible for re-el¢¢lion. The Directors retiring by rotation the following July 2024 AGM are thus Dr, Joan Walion and
Mr. Paul Kieniewicz.
All those retiring are eligible for re-election. Co-opted directors have a temi of close to a year, before being voted in as full
Board members.
There are now up lo five possible vacancies for Directors to be elected at the Annual General Meeting and len current
applications. There are four further vacancie5 available by co-option by the Board.
On 31$1 December, 2023. the members of the Company were Ms. Jaquelin¢ Nielsen, Mr. Tuvi Orbach, Mr. Paul
Kieniewi¢4 Dr. Joan Walton, and Dr. Vasileios Bhsios. The members are the guarantors, ¢a¢h in a sum not exceeding £1.
OWECTIVES AND ACTtVlTIES
The Charity's objects are set out in the Memorandum 8nd Articles of Association are'.- for the benefit of the public. to advance
education in the study and application of science and medicine, in particular but not exclusively, by adopting an
interdisciplinary approach.
The Directors conflrn) that they have referred to the guidance contained in the Charity Commission's general guidance on
public benefit when reviewing the Charity's objeclives and activities.

THE SCIEIYTIFIC AND MEDICAL NETWORK
BOARD OF TRUSTEES? REPORT
FOR THE YEAR ENDED 31" DECEMBEIL 2023
ACHIEVEMENTS AND PERFORMANCE
Review of the Y¢ar
During the year, th¢ Company continued the edLEcational activities previously undertaken, by arranging ￿nferenCeS and
webinars on subjects relevant to its charitable purposes. These were open to the public. During the year our finances
coniinued to improve, although this was only achieved thanks to a very generous donalion of £1 00,000 in memory of the
late John Kapp. In consultation with the Donor, this sum has been designated by the Trustees for use on two projects as set
out in note 2. Also work on various educational projects jointly with partners continued. Further details of the projects are
given in the Paradi8m Explorer journal, which is edited, published and distributed to members of the Ne￿ork and others,
Ihree times a year.
The Accounts for the year ended 31st December, 2023 show a surplus of income over expenditurc of £66.915. This
compares to a restated deficit of £23.866 in 2022. However. as mentioned above. had it not been for the £100.000
donation. the current year would have shown a deficit of £33.085. This demonstrates that there is still work to do to
improve our recurring income and in so doirtg. improve our general fund which stands al £25.799 at year end compared lo
£39,689 a year ago. In January 2024, Ihe Salvia Foundation extended its support of the Galileo Commission project for a
further three years to December 2026 at a rate of £75,000 per hnnum. Income from Charitable Activities has in¢reased in
all areas as set out in mor¢ d¢tsil in note 4 to th¢ accounts, including from the AGM which ha5 been run in a physi¢al
forniat again. Webinar income has again perfom)ed strongly and film income is rising pleasingly, In addilion to this, a
legacy of £12,454 was received in the year under review.
The Directors have detennined thai despite the income level in the year under review being insufficient to increase our
General Fund. il was suffi¢ieni to cover our charity aims. We iherefore have not had to depend on the support of the Trust.
Our Trust does provide us with an annual letter to guarantee funds well in excess to our annual needs, to cover any
conlin8en¢y. The B0￿d continues lo actively look at ways to in¢re&se revenues and reduce costs. The website has
ontinu¢d lo be developed and is helpin8 US to become rnor¢ visible to the public.
Asking for donations, and particularly for legacies, continues to be an important way of maintaining the Netsyork in the
longer tenn, and the Board is very grateful for this type of support, and continues to actively seek these, where and when it
is appropriate.
FINANCIAL REVIEW
The Dircclors moniior the resources of the Charity to ensure that sufficient funds arc maintained to meets its future needs
and to ensure thal it has sufficient working capital. At 3 1st December, 2023. the Charity had reserves of £126,779
compared to £59,864 the previous year. The Director5 are considering ways lo further improve and ensure thc financial
sustainability of the Charity, and consider it as a going concern.
PLANS FOR FUTURE PERIODS
As with the last year, we are expecting a steady increase in membership and thus subscription income. Regretfullyi our
organisation h&s not been immune to the cost inflation experienced over the pasl couple of years and we are actively
reviewing the subscription rates to improve our financial position. Our administration of increased members and increased
event attendance, has required taking on more stsff and challenged our operational and governance procedures. We are still
in the situation of change but hope lo have ourselves restructured by the end of 2024. The Directors continue to review
every aspecl of the Company's activities to increase revenues and to restrain costs. This includes.. keeping events
inexpensive and thus attractive to delegates. widening markeiing particularly via the website and so encouraging the
attendance of more non-members. and finally to markei to and attract a younger demographic to events and so further
extend our educational support (which also has the benefit of starting to redress our membership age profile).
In addition, we will Continue to mount our usual annual programme of public conferences and lectures virtually, but
Monitor carefully the possibility of Teturning to some in-person evenls. The Msc course is continuing, as is the successful
Galileo Commission project, and our new 'Young people. (New Paradigm NavigatOTS) project. Students continue to be
offered discounted membership to cnable access to our educational resources and support vi4 for exampl¢, targeted
webinars, social networking, and virtual webinars.

THE SCIENTIFIC AND MEDICAL NETWORK
BOARD OF TRUSTEES• REPORT
FOR THE YEAR ENDED 31st DECEMBEIL 2023
DIRE￿oRs, RESPONSIBILITIES STATEMENTS
The Trustees (who are also the Directors of the Scientific and Medical Ne￿ork for th¢ purposes of eA)mpany law) are
responsible for preparing the Directors Annual Report and ihe financial ststemenls in a¢cordan¢e wilh applicable law and
regulations.
Company law requires ihe Trnst¢¢s lo prepar¢ financial ststements for each financial year which give a true and fair view of
the stale of affairs of the charitable company and of the incoming resources and application of resources. including the
income and expenditure of the charitable cornpany for that period. In preparing ihese financial statements. the Trustees are
required to..
select suitabl¢ accounting policies and then apply them consistenily;
observe the methods and principles in the Charities SORTr.
make judgements and estimates thai arc reasonable and prudent;
state whether applicable accounting standards have been followed, subject lo any material departures disclosed and
explained in the financial statements;
prcparc the financial statements on ihe going concem basis unless il is inappropriate to presume that the Charity
will continue in operation,
The Board of Trustees has overall ￿spOnSibl]Ity for ensuring that the Charity has an appropriaie system of controls, financial
and otherwise. They are also responsible for keeping adequate accounting records which disclose with reasonable accuracy
at any time ihe financial position of the Charity and enable them to ensure that the financial statements comply wilh the
Companies Act 2006, the Charities Act 201 I, and the provisions of the governing document. They are also responsible for
safeguarding the assets of the Charity and hence for taking reasonable steps for ihe detection and prevention of fraud and
other I￿egular1tieS.
The Board of Trustees is responsible for the mainienan¢e and integrity of the corporate and financial infomation included
on the Company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial
statements may differ from le8islation in other jurisdictions.
Approved by the Board of Trusiees on 14 July 2024 and signed on their behalf by'.-
Paul Kieniewicz
Trustee

THE SCIENTIFIC AND MEDICAL NETWORK (Registered Company No. 04544894)
llYDEPENDENT EXAMINER'S REPORT TO THE MEMBERS OF
THE SCIENTIFIC AND MEDICAL NETWORK
FOR THE YEAR ENDED 31" DECEMBE￿ 2023
I report to Ihe Charity Trustees on my examination of the financial statements of The Scientific and Medical
Nelwork for the year ended 31 $t December, 2023.
Responsibilities and Basis of Report
As the Trustees of The Scientific and Medical Network (and also its Directors for thc purposes of company law) you are
responsible for the preparation of the Accounts in accordance with the requirements of ihe Companies Act 2006 ('the 2006
Act,). You are satisfied that the Accounts of the Company are not required by charity or company law to be audited and
have chosen instead to have an independent examination.
Having satisfied myself that the Accounts of The Scientific and Medical Network are not required to be audited under Part
16 of the 2006 Act and are eligible for independent examination. I report in respect of my examination of the Accounts
Carried oul under Section 145 of the Charilies Acl 2011 Cthe 201 l Act,). In carrying out my examination I have followed
the Dire¢tions given by the Charity Commission undcr Scction 145(5)(b) of the 2011 Act.
Ind¢pend¢nt Examlner's Statemenl
I can confimi thai l am qualified to undertake the examination because l am & re8iStered member of the ACCA which is one
of ihe listed bodies.
I have completed my examination. I confimi Ihat no matters have ￿me to my attention in connection with the examination
giving me cause to believe that in any material respect..
accounting records were not kept as required by Section 386 of the 2006 Act; or
Ihe accounts do not accord wilh those re¢ords' or
the accounts do not comply with the accounting requirements of Seeiion 396 of the 2006 Act other than any
requirement that the accounts give a true and fair view which is not a matter considered &8 part of an independent
examination.
J have no concerns and have wme across no other rnatters in ¢onneciion with the examination to which attention should be
drawn in this report in order to enable a proper understanding of the accounts to be reached.
Andrew M. Farr, FCCA,
Dawe, Hawken & Dodd
Chartered Certified Accountants
52 Fore Street
Callington
Cornwall
PL17 7AJ
Date.. i oth July, 2024

THE SCIENTIFIC AND MEDICAL NETWORK
STATEMENT OF FINANCIAL AcT￿lTIEs
(incorporating the Income and Expenditure Account)
FOR THE YEAR ENDED 31" DECEMBEW 2023
Unrestrieted Restricted
Funds
Funds
Note
2023
2022
As
reststed
(note 14)
INCOME AND ENDOWMENTS FROM:
Donations and Lega¢i¢s
Income from Charitable Activities
Other Income
120380
270590
6924
38000
158380
270590
6924
93336
177830
5125
TOTAL
397894
38000
435894
276291
EXPENDITURE ON:
Charitable Activities
311784
57195
368979
300157
TOTAL EXPENDITURE
311784
57195
368979
300157
Net Income/(Expenditure)
Net Transfer beMeen Funds
Net Incomingl(Ouigoing) resources
after Transfers
86110
(19195)
66915
(23866)
86110
19195
66915
23866
NET MOVEMENT IN FUNDS
86110
(19195)
66915
(23866)
Total Funds at ljl Janu*ry• 2023
Prior Year Adjustment
Funds 8t 31# December, 2023
39689
20175
59864
111577
14
(27847)
59864
125799
980
126779
The notes on pages 10 to 15 fomi part of these financial statements

THE SCIENTIFIC AND MEDICAL NETWORK
BALANCE SHEET
AS AT31" DECEMBE￿ 2023
Note5
2023
2022
restated
(note 14)
FIXED ASSETS
Tangible Assets
Current Assets
227
307
Debtors
C&sh at Bank and in Hand
1356
19229
203036
121340
CREDITORS; Amounts falling due
within one year
io
17
NET CURRENT ASSETS
955
TOTAL ASSETS LESS CURRENT LIABILITIES
126779
NET ASSETS
12
126779
FUNDS
Unrestricted funds:
General Fund
Designated Funds
25799
00
39689
125799
39689
Restrict¢d Funds
The Company is exempt from the requirements relating to preparing audited accounts in dcGordance with Section 477 of the
Companies Act 2006, The members have not required the Company to obtain wi audil of its accounts for the year ended 3111
December, 2023 in accordance with Section 476 of the Companies Act 2006.
The Dtrectors acknowledge their responsibilities for complying with the requirements of the Companies Ad 2006 with
respect to accountin8 records and the preparation of accounts. These accounts have been prepared in accordance with the
provisions applicable to companies subject to the small companies, regim¢.
The financial statements were approved. and authorised for issue, by the Board of Trustee5 on 14 July 2024
and signed on their behalf by:"
Dr. Vasileios Basio
Trusiee
te
n pages 10 to 15 forni part of ihese finan¢ial slat¢m¢nts

THE SCIENTIFIC AND MEDICAL NETWORK
CASH FLOW STATEMENT
FOR THE YEAR ENDED 3191 DECEMBE￿ 2023
2023
2022
As restated
(note 14)
Cash Flows from Operating Activities
Surplusl(deficit) for th¢ financial year
66915
(23866)
Adjustment$ for:
Depreciation
(Increase)/Decre8se in Debtors
In¢r¢asellDe¢rease) in Creditors
342
755
4701
414
(2111)
2641
82713
(22922)
Cash Flows from Inves¢ing Activities
Purchase of Tangible Fixed Assets
Nel (D¢crea$e)Iln¢rease In C4$h #nd Ca$h Equivalen¢$
Cash and Cash Equivalents at Im January, 2023 and 2022
CA%h Ind CAsh EqulvAlents at 31" December, 2023 and 2022
26
82451
(22929)
1421
Components of Cash and Cash Equivalents
Cash at Bank and in Hand
22

THE SCIENTIFIC AND MEDICAL NETWORK
NOTES TO THE FINAIYCIAL STATEMENTS
FOR THE YEAR ENDED 31" DECEMBEII 2023
ACCOUNTING POLICIES
Basis of Preparation of Fin2nei21 Statements
The financial statements of the Charity. which is a public benefit entity under FRS102, have been prepared under the
historical cost convention. They have been prepared in accordance with applicable Uniied Kingdom a¢counting
standards, the requirements of the Statement of Recommended Practice Accounting and Reporting by Charities
(SORP 2015), the Financial Reporting Standard applicable in the UK (FRS 102) and the Companies Act 2006.
The Trustees consider that there are no material uncertainlie5 about the Trust's ability to continue as a going r￿ncern.
Company Status
The Scientific and Medical Network is a eomphny limited by guarantee. In the event of the Charity bein8 wound up,
the liability in respect of the guarantee 15 limited to £1 per member of the Charity.
Fund Accounting
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the
general object5 of the Charity and which have not been designated for other purposes.
Designated fund5 comprise unrestricted fijnds that have been set aside by the Trustees for particular purposes. The
aim and use of each designated fund is set out in the notes to the financial statements.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors which
have been raised by the Charity for particular purposes. The cost of administering such funds are charged against the
specific fund. The aim and use of each restricted fund is set out in the notes to the financial staiements. Sta￿tOry
grants which are given a5 contributions towards the Charity's core scrvice$ are treated as unrestricted.
In¢omln8 Re$our¢es
All in¢oming resources are included in the Statement of Financial A¢tiviti¢s when the Charity is legally entitled to
the income and th¢ amount can be quantified with reasonable ￿¢VraCY.
Gifts in kind donated for distribution ore included at valuation and recognised &s income when they ate distributed to
the projects. Gifts donated for resale are included a5 income when they are sold. Donated facilities are included at
the value to ihe Charity where this can be quantified and a third party is bearing the cosl. No amounts are included
in the financial statements for services donaled by volunteers.
Donated services are included in income at a valuation which is an estimale of the financial Cost tM)me by the donor
where such a cost is quantifiable and measurable. No incorne is recognised where there is no financial cost born¢ by
a third party.
Income Tax re¢ov¢rable in relation lo investment inwme or Gift Aid donations is recognised at the time the relevant
income is receivable.

10.
THE SCIENTIFIC AND MEDICAL NETWORK
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31" DECEMBER, 2023
Resources Expended
All expenditure is accounted for on an accruals basis and has been included under expense categories that aggregate
all costs for allocation to activities. Supwrt costs, which cannot be directly attributed to particular activilies, have
been apportioned proportionately to the dire¢1 staff costs allocated to the activities. Governance costs include the costs
of servicing Trustees, meetings, independent examination and strategic planning.
Irrecoverable VAT is charged against the category of resources expended for which it was incurred.
Tangible Fixed Assets and Depreciation
Tangible fixed assets are staled at cost less depreciation. Depreciation is provided al rates calculated to write off the
cost of fixed assets, less their estimaled residual value, over their expecied lives on the following bases..
Office Equipment
4 Years
DONATIONS, GRANTS AND LEGACIES
Unrestricted
Funds
Restricted
Funds
2023
2022
Donations
Legacies
Grants
107926
12454
107926
12454
38000
20625
16957
55754
38000
120380
38000
158380
93336
Analy$ls of the Grants Fundlng
Waison Grant
Salvia Foundation Grants
17754
38000
38000
38000
38000
38000
55754
The Directors have designated that donations of £IOO,000 will bc used for two specific projects as follow5:
Young persons projeol (New Paradigm Navigations)
Galileo Commission activity
30.000
The New Parddigm Navigation Project aim5 to engage young people with SMN by creating a 5UPPOrtiv¢ space for
collaborative enquiry, enabling them to addre55 Societal issues and discover their innate wisdom ihrough the Heart
Sense approach.
The Galileo Commission is a large divisional project within the SMN that encompasses multiple sub-projects and
aclivitie5 including online and physical events. The mission is to expand the framework of science by challenging the
lirnitations of scientific materialism.

ii.
THE SCIENTIFIC AND MEDICAL NETWORK
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED31" DECEMBEIL 2023
OTHER INCOME
Unrestrieted
Restricted
2023
2022
Funds
Funds
Publication Income & Book Sales
Grants Administration Fees
Interest
4755
2000
169
6924
4755
2000
169
6924
2134
2934
57
5125
INCOME FROM CHARITABLE ACTIVITIES
Unr¢strlcted
Restrleted
2023
2022
As
restated
(note 14)
Funds
Funds
Membership Fees
AGM Sales
Mystics and Scientists
Beyond the Brain including film viewings
Film Viewings
Online Edu￿tiOn including Webinars
CPF
Other Event Sales
91248
21617
16200
29951
6036
77826
9631
18081
270590
91248
21617
16200
29951
6036
77826
9631
18081
270590
77030
6249
19504
1760
52264
8623
12400
177830

12.
THE SCIENTIFIC AND MEDICAL NETWORK
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31$t DECEMBEK 2023
RESOURCES EXPENDED
Unrestricted
Funds
Restricted
Funds
2023
2022
Event Costs:
AGM Expenses
Mystics and Scientists
Beyond the Brain
CPF
her Events
Total Event Cost$
22871
4989
7857
3452
13084
52253
22871
4989
7857
3452
13084
52253
2455
5621
1386
9132
18594
Membership Discounts
Publicaiion Costs
Webinars
Salvia Foundation
Watson Grant
Galileo
Support Costs
YP Project
450
34085
29108
450
34085
29108
39441
17754
630
30846
21278
43835
39441
17754
1500
181694
1780
185461
10427
185461
10427
Total Charitable Expenditure
311784
57195
368979 300157
Resources expended include..
2023
2022
Ind¢pendenl Examiner's Fee
Depre¢iation
1920
342
1552
414
Details of Staff Costs are given in Note 7
Details of Support Costs are given in Note 6.
SUPPORT COSTS
Total
2023
Total
2022
Administration
Depreciation
Independent Examiner's Fee
Tax Advice and Accounting Software
Postage, Stationery & Freight
Staff Costs
Bank Charges
Consultancy Fees
Advertising and Marketing
Social Media Marketing
Travel
8048
342
1920
1109
6990
50826
8979
93564
245
12000
1438
185461
13829
414
1552
3875
451
46634
7147
98887
376
6985
1544
181694

13.
THE SCIENTIFIC AND MEDICAL NETWORK
NOTES TO THE FtNANCIAL STATEMENTS
FOR THE YEAR EIYDED 31" DECEMBER, 2023
STAFF NUMBERS AND COSTS
2023
2022
Wages and Salaries (in¢luding employers MC)
Pension Cosls
49619
1207
45643
Average number of employees
No employee received remuneration of more than £60.000.
During the year. key management r￿e1ved remunerdtion of £48.660 (2022 - £45.640). Highest remunerntion was for
David Lorimer (paid &8 a consultant) of £47,049 plus expenses of £1.710.25 There were payments madc lo 3 members
of the Board of Trustees in the year. Insighi Centre Ltd. (Paul Filmore) received £10,800 (incl. VAT) for managemeni
and finance work and expenses of £245. Joan Walton received £4,140 for Galileo Commission Steering Group
Honorarium. Development Day and YP Project and reimbursement of expenses of £1,444.54; V&sileios Basios
received £3.000 for Galileo Commission Steering Group Honordrium.
TANGIBLE FIXED ASSETS
Office
Equipment
Co$1
At 1° January, 2023
Additions
Disposa15
At 3111 December, 2023
9934
262
Deprttiation
Ai I It January, 2023
Charge for the Year
Disposals
Al 3 1st December, 2023
9627
342
82
1694
Net Book VAIu¢
At 31S1 December, 2023
At 31° December, 2022
DEBTORS
2023
2022
Due within one year
Prepayment$ and A¢¢rued In￿rne

14.
THE SCIENTIFIC AND MEDICAL NETWORK
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31" DECEMBER, 2023
10 CREDITORS: Amounts falling due wlthin one year
2023
2022
reststed
(note 14)
Deferred Income
Social Security and Other Taxes
Other Crediiors & Accruals
48918
3386
4180
484
40841
2807
17
11. STATEMENT OF FUNDS
Brought
Forw*rd
A5 restated
{no¢e 14)
Incoming
Resourees
Resources
Expended Tr4nsf¢rs
Carried
Forward
RESTRicfED FUNDS
Blaker Educational Fund
Galileo
Salvia Foundation Grant
Watson Grant
Theoria to Theory Fund
61
350
1275
17754
735
20175
61
184
(166)
166
38000
39441
17754
735
980
38000
57195
SUMMARY OF FUNDS
Designated Funds
General Funds
Restricted Funds
i 00000
( i 00000)
iooooo
25799
980
126779
39689
20175
59864
397894
38000
435894
311784
57195
368979
12. ANALYSIS OF NET ASSETS BETWEEN FUNDS
Unres¢rlc¢¢d Funds
Designated
General
Funds
Fund$
Restricted
Funds
Totsl
Funds
Tangible Fixed Assets
Current Assets
Less: Current Liabilities
NET ASSETS
227
102056
76484
257
227
203036
100000
980
10
980
12

15.
THE SCIENTIFIC AND MEDICAL NETWORK
NOTES TO THE FIIYANCIAL STATEMENTS
FOR THE YEAR ENDED31" DECEMBE￿ 2023
13. COMPARATIVE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
Funds
2022
Restricted
Funds
2022
Totsl
2022
restAted
(note 14)
re8t*¢ed
(nole 14)
INCOME AND ENDOWMENTS FROM:
Donations and Legacies
Charitable Activities
Other Income
37582
177830
5125
55754
93336
177830
5125
TOTAL
220537
55754
276291
EXPENDITURE ON:
Charitable Activities
254822
45335
300157
TOTAL EXPENDITURE
254822
45335
300157
Net Incomel(Expendilure)
Transfer between Funds
Net Incomingl(Oul8oing) re$ources
after Transfers
(34285)
10419
(23866)
(34285)
10419
(23866)
NET MOVEMENT IN FUNDS
Tot21 Funds at lit JAnugry• 2022
Total Funds at 3111 Deeember, 2022
73974
9756
83730
39689
20175
59864
14.
PRIOR YEAR ADJUSTMENT
In previous years membership subscriptions have been recognised as income on the dale that payment was
received. Fnllnwin8 a r¢vi¢w by ihe Board it is feli rnure appropriate to spread the membership fee over the year
of membership, ne¢essitaiing an adjusiment to be made to the accounls to reflect the unexpired time value on
membership fees paid as at the end of the financial year. The prior year adjustment reflects the unexpired time
value of memberships as al 31 December 2021 and the COmp￿atiVe figures for membership fees in the year
ended 31 December, 2022 have been adjusted to reflect the position at that year end.